Bovine leukosis starts with bovine leukemia virus (BLV), an oncogenic retrovirus that infects cattle for life. Most infected cows stay healthy, a minority develop a benign lymphocytosis, and fewer than 5 percent develop lymphosarcoma in adulthood. The NAVLE tests the difference between enzootic (BLV) and sporadic lymphosarcoma, the typical tumor sites and the signs they cause, serology versus biopsy, and how to stop spread by blood.
Key facts
Lymphoma (leukosis, BLV) at a glance- Species and system: cattle; lymphoid tissue and many organs.
- Cause: BLV, an exogenous C-type oncogenic retrovirus of the BLV-HTLV group. Infection is lifelong; the virus does not cause chronic viremia.
- Outcomes: most remain asymptomatic; about 29 percent develop persistent lymphocytosis; under 5 percent develop lymphosarcoma, most often at 4 to 8 years.
- Sporadic forms (unrelated to BLV): juvenile (under 6 months), thymic (6 to 24 months) and cutaneous (1 to 3 years).
- Diagnosis: ELISA for infection; cytology or histopathology for lymphosarcoma.
- Treatment: none for infection or tumor; no vaccine.
- Zoonotic: not typically considered zoonotic, but BLV DNA has been found in human tissue and the risk is unresolved.
What's inside
12 sections in the full guide- Key facts
- How the NAVLE tests this
- Cause and pathophysiology
- Clinical signs
- Diagnosis
- Differential diagnoses
- Treatment and management
- Prevention, control and public health
- Prognosis
- Quick review
- Test yourself
- References
The full guide also has 4 tables, 3 self-test questions and 3 references, available to NAVLE members.
Read the full study guide
The full guide is part of every NAVLE plan, with diagnosis and treatment tables, figures, a quick review and self-test questions. Start a free trial to try the question bank, or log in if you are already a member.